search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Digital Printing


Die Pharmadrucker puts Screen 520HD+ at heart of plan to move pharmaceutical printing to a digital future


A


fter undertaking a thorough selection process and extensive testing, Die Pharmadrucker announced it has made the Screen Truepress 520HD+ the pivot of its ambitious plan to shift pharmaceutical printing towards a digital, more efficient and flexible future.


Die Pharmadrucker, a spin-off of the centuries-old German Bernecker printing company, believes it can enhance value creation in the pharmaceutical market for itself and its partners; mostly mid-size and small pharmaceutical companies. Screen’s digital inkjet offering was able to solve the particular challenge of printing on the thin paper that is typically used for pharmaceutical leaflets and safety instructions for medicine labels. The Screen Truepress Jet 520HD+ prints on 40gsm paper at offset quality and at high speeds.


COVID TO BOOST ONLINE PRINT SHOP Die Pharmadrucker wants to set a new standard for the industry. “Most specifically, for the companies that produce pharmaceutical inserts,” says Sebastian Härtig, a member of Die Pharmadrucker’s management team. He sees a future where print jobs are ordered in Die Pharmadrucker’s web shop, imported directly into its system, and printed and delivered within 24 hours. The coronavirus crisis will likely accelerate this shift to remote online ordering of print jobs, and highly automated processing and printing, according to Härtig.


Die Pharmadrucker wants to share the insights it gained while exploring digital printing options with its partners, mostly mid-size pharmaceutical companies across Europe. “Relatively few companies have made the journey we’ve made. We’re keen


to share our experiences with peers and partners to help resolve challenges they may be facing in their quest to move to digital printing”, explains Mr Härtig.


These challenges include meeting the relatively stringent regulatory requirements in the pharmaceutical printing market. Several companies have already shown interest in learning more, and Die Pharmadrucker is planning demonstrations of its new production line, which it has dubbed a ‘Smart factory’.


u diepharmadrucker.de


Schreiner MediPharm equips Cap-Lock security label with RFID technology


S


chreiner MediPharm has enhanced its tamper-evident specialty label, Cap-Lock, with a special RFID inlay. Developed to help hospitals expand digitisation initiatives, the label-and-cap security concept for prefilled syringes now also enables automated inventory and supply chain management, as well as digital first-opening indication.


Equipping syringes containing liquid medications with RFID-Labels poses a challenge, as both the container material and the composition of the liquid may impair reading of a UHF RFID-Label. Flag labels are frequently used for this purpose., however, they typically require additional space, are prone to being torn off and must be applied manually.


With Cap-Lock plus RFID, the RFID chip is integrated in the label. Cap-Lock is a combination of a cap adapter and label. The


adapter is placed on top of the syringe’s primary closure and interlinked with it to equalise the diameter differences of the syringe body and closure. The label wraps around the syringe body and cap adapter and, once opened, provides irreversible tamper evidence, due to an integrated perforation.


The RFID inlay is located in the upper part of the label at the level of the cap, largely sitting outside the liquid-filled area and enabling reliable long-range reading. Due to the RFID functionality, digital first-opening


evidence is now possible in addition to the previous, purely visual first-opening indication provided by the destroyed label. For live monitoring and control of the logistic flow of materials and products in automated inventory and supply chain management, the data of syringes equipped with RFID-Labels can be automatically captured at various stations. Additionally, integrity, first-opening or tampering with containers can be digitally monitored. In medication management, data stored on the RFID-Labels is read automatically either individually or in bulk using handheld or specialty readers, and matched with a database. This enables exact tracking of inventories and provides transparency regarding medicines that are missing or approaching their expiration date.


u schreiner-medipharm.com


convertermag.com


November 2020


31


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44